DYAI

Dyadic International (DYAI)

About Dyadic International (DYAI)

Dyadic International, Inc. engages in developing a gene expression platform for producing commercial quantities of industrial enzymes and other proteins. It focuses on further improving and applying its proprietary C1 technology, which is used in the discovery, development, and manufacture of biologic medicines and vaccines. The company was founded by Mark A. Emalfarb in 1979 and is headquartered in Jupiter, FL.

Details

Daily high

$2.05

Daily low

$1.72

Price at open

$1.98

52 Week High

$2.67

52 Week Low

$0.93

Market cap

51.8M

Dividend yield

0.00%

Volume

266,197

Avg. volume

106,140

P/E ratio

-8.02

Dyadic International News